The latest pancreatic cancer news
New drug doubles one-year survival in pancreatic cancer trial
In a randomized phase 2 clinical trial, patients who received the experimental drug elraglusib, alongside…
Browsing: Pancreatic Cancer
Elraglusib plus chemotherapy associated with improved survival in metastatic pancreatic cancer
A randomised phase 2 trial published in Nature Medicine has evaluated the addition of elraglusib,…
Growth of spreading pancreatic cancer fueled by ‘under-appreciated’ epigenetic changes
In a lab-grown cell study focused on potential new treatment targets for halting the spread…
5-FU chemotherapy linked to rare brain toxicity in cancer patient
A new case report was published in Volume 12 of Oncoscience on December 23, 2025, titled “Silent toxicity:…
Triple-targeted therapy shows unprecedented efficacy in early pancreatic cancer models
Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest common cancers, with historically limited therapeutic…
Researchers identify new blood markers that may detect early pancreatic cancer
National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal…
Promising target improves antitumour response in preclinical models of pancreatic cancer
Researchers at The University of Texas MD Anderson Cancer Centre have found that a mitochondrial enzyme, GFER,…
Octopus-inspired 3D micro-LEDs pave the way for selective pancreatic cancer therapy
Conventional pancreatic cancer treatments face a critical hurdle due to the dense tumour microenvironment (TME).…
Scientists develop one-product-fits-all immunotherapy for pancreatic cancer
Pancreatic cancer is among the deadliest forms of cancer, with most patients diagnosed after the…
High-risk individuals with mild dilatation of the pancreatic duct have increased risk for pancreatic cancer
Pancreatic ductal adenocarcinoma is projected to become the second-leading cause of cancer death in the…